141 related articles for article (PubMed ID: 37220284)
1. Paraneoplastic or treatment-associated dermatomyositis: a diagnostic challenge.
Esperanca-Martins M; Damaso S; Carreira N; Pena B; Correia C; Aguado-Lobo M; Espinosa-Lara P; Soares-de-Almeida L; Abreu Ribeiro L; Costa L
Dermatol Online J; 2023 Apr; 29(2):. PubMed ID: 37220284
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
3. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
Kubeček O; Soukup T; Paulík A; Kopecký J
BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
[TBL] [Abstract][Full Text] [Related]
4. Dermatomyositis presenting as a paraneoplastic syndrome due to underlying breast cancer.
Sandhu NP; Zakaria S; Degnim AC; Boughey JC
BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22714621
[TBL] [Abstract][Full Text] [Related]
5. Syndrome in question.
Esposito AC; Munhoz T; Ocanha JP; Miot HA
An Bras Dermatol; 2016; 91(3):387-9. PubMed ID: 27438215
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic syndrome and underlying breast cancer: a worsening rash despite initiation of chemotherapy.
Ahuja S; Makkar P; Gupta S; Vigoda I
J Community Support Oncol; 2016 May; 14(5):229-31. PubMed ID: 27258056
[TBL] [Abstract][Full Text] [Related]
7. Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches.
Didona D; Solimani F; Caposiena Caro RD; Sequeira Santos AM; Hinterseher J; Kussini J; Cunha T; Hertl M; Didona B
Ital J Dermatol Venerol; 2023 Apr; 158(2):84-98. PubMed ID: 37153943
[TBL] [Abstract][Full Text] [Related]
8. Dermatomyositis and Paclitaxel-Induced Cutaneous Drug Eruption Associated with Metastatic Breast Cancer.
Kim Y; Jung W; Park YH
J Breast Cancer; 2015 Jun; 18(2):195-9. PubMed ID: 26155297
[TBL] [Abstract][Full Text] [Related]
9. Lambert-Eaton Myasthenic Syndrome and Dermatomyositis With Anti-TIF1-gamma Autoantibody: A Unique Association of Autoimmune Neuromuscular Conditions Without Malignancy.
Isfort M; Mnatsakanova D; Oddis C; Lacomis D
J Clin Neuromuscul Dis; 2021 Mar; 22(3):164-168. PubMed ID: 33596001
[TBL] [Abstract][Full Text] [Related]
10. A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer.
Piras M; Panebianco M; Garibaldi M; Roberto M; Merlonghi G; Pellegrini P; Marchetti P
Curr Oncol; 2021 May; 28(3):1957-1961. PubMed ID: 34073827
[TBL] [Abstract][Full Text] [Related]
11. How can we effectively address the paraneoplastic dermatomyositis: Diagnosis, risk factors and treatment options.
Zerdes I; Tolia M; Nikolaou M; Tsoukalas N; Velentza L; Hajiioannou J; Mitsis M; Kyrgias G
J BUON; 2017; 22(4):1073-1080. PubMed ID: 28952230
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C; Kato J; Toda N; Imai M; Fukumura Y; Arai J; Kurokawa K; Kondo M; Takagi K; Kojima K; Ohki T; Seki M; Yoshida M; Suzuki A; Tagawa K
J Med Case Rep; 2019 Jun; 13(1):168. PubMed ID: 31153385
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy.
Russo R; Gasparini G; Cozzani E; Gravina B; Parodi A
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454323
[TBL] [Abstract][Full Text] [Related]
14. Anti-TIF-1α/γ Antibody-Positive Dermatomyositis Associated With Metastatic Prostatic Adenocarcinoma.
Psomadakis CE; Maron SZ; Ng MJ; Kessler AJ; Bryce CH; Shanker VL; Scelsa SN
J Clin Neuromuscul Dis; 2021 Dec; 23(2):100-104. PubMed ID: 34808651
[TBL] [Abstract][Full Text] [Related]
15. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic dermatomyositis accompanying nasopharyngeal carcinoma: diagnosis, treatment and prognosis.
Chakroun A; Guigay J; Lusinchi A; Marandas P; Janot F; Hartl DM
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jun; 128(3):127-31. PubMed ID: 21257359
[TBL] [Abstract][Full Text] [Related]
17. Dermatomyositis: A Presenting Clinical Vignette in a Patient With Breast Cancer.
Allouch A; Zaatarikahale TB; Moussa MK; Jounblat Y; Bitar N
Cureus; 2020 Sep; 12(9):e10624. PubMed ID: 33123437
[TBL] [Abstract][Full Text] [Related]
18. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
[TBL] [Abstract][Full Text] [Related]
20. Anti-TIF1γ-Dermatomyositis and Sjögren's Syndrome As the Inaugural Presentation for Rectal Cancer.
Oliveira Santos M; Santos I; Sacramento G; Oliveira R; Castanheira A
Cureus; 2024 Mar; 16(3):e55978. PubMed ID: 38618380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
